|
|
||||||||

* Cytos Biotechnology AG, Zurich-Schlieren, Switzerland; and
Swiss Federal Institute of Technology, Institute of Integrative Biology, Molecular Biomedicine, ETH Zurich, Switzerland
Although IgG2a is the most potent Ab isotype in the host response to viral and bacterial infections, the regulation of class switch recombination to IgG2a in vivo is not yet well understood. Recognition of pathogen-associated molecular patterns by dendritic cells expressing TLRs, like TLR7, recognizing ssRNA, or TLR9, recognizing DNA rich in nonmethylated CG motifs (CpG), favors induction of Th1 responses. It is generally assumed that these Th1 responses are responsible for the TLR-mediated induction of IgG2a. Using virus-like particles loaded with CpGs, we show here that TLR9 ligands can directly stimulate B cells to undergo isotype switching to IgG2a. Unexpectedly, TLR9 expression in non-B cells did not affect isotype switching in the Ab response against virus-like particles. Thus, TLR9 can regulate isotype switching to IgG2a directly by interacting with B cells rather than indirectly by inducing Th1 responses.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Address correspondence and reprint requests to Dr. Martin F. Bachmann, Cytos Biotechnology AG, Wagistrasse 25, 8952 Zurich-Schlieren, Switzerland. E-mail address: martin.bachmann{at}cytos.com
2 Abbreviations used in this paper: VLP, virus-like particle; DC, dendritic cell.
This article has been cited by other articles:
![]() |
C. Ding, L. Wang, J. Marroquin, and J. Yan Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1 Blood, October 1, 2008; 112(7): 2817 - 2825. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu and Z. Li Endoplasmic reticulum HSP90b1 (gp96, grp94) optimizes B-cell function via chaperoning integrin and TLR but not immunoglobulin Blood, August 15, 2008; 112(4): 1223 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xu, P. A. Santini, A. J. Matthews, A. Chiu, A. Plebani, B. He, K. Chen, and A. Cerutti Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF J. Immunol., July 1, 2008; 181(1): 276 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lembo, M. Pelletier, R. Iyer, M. Timko, J. C. Dudda, T. E. West, C. B. Wilson, A. M. Hajjar, and S. J. Skerrett Administration of a Synthetic TLR4 Agonist Protects Mice from Pneumonic Tularemia J. Immunol., June 1, 2008; 180(11): 7574 - 7581. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gao, P. Jennings, and D. Yuan Requirements for the natural killer cell-mediated induction of IgG1 and IgG2a expression in B lymphocytes Int. Immunol., May 1, 2008; 20(5): 645 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Gargano, J. M. Moser, and S. H. Speck Role for MyD88 Signaling in Murine Gammaherpesvirus 68 Latency J. Virol., April 15, 2008; 82(8): 3853 - 3863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Rubtsov, C. L. Swanson, S. Troy, P. Strauch, R. Pelanda, and R. M. Torres TLR Agonists Promote Marginal Zone B Cell Activation and Facilitate T-Dependent IgM Responses J. Immunol., March 15, 2008; 180(6): 3882 - 3888. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Meyer-Bahlburg, S. Khim, and D. J. Rawlings B cell intrinsic TLR signals amplify but are not required for humoral immunity J. Exp. Med., December 24, 2007; 204(13): 3095 - 3101. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Cunningham, F. Gaspal, K. Serre, E. Mohr, I. R. Henderson, A. Scott-Tucker, S. M. Kenny, M. Khan, K.-M. Toellner, P. J. L. Lane, et al. Salmonella Induces a Switched Antibody Response without Germinal Centers That Impedes the Extracellular Spread of Infection J. Immunol., May 15, 2007; 178(10): 6200 - 6207. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |